![Bill Aprea](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bill Aprea is Chief Compliance Officer & Senior Vice President at Phathom Pharmaceuticals, Inc. since 2025.
Formerly, Mr. Aprea was Executive Director-Senior Franchise at Celgene Corp.
Education includes undergraduate studies at Rutgers State University of New Jersey and graduate studies at Rutgers University- Newark.
| Società | Posizione | Inizio |
|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Responsabile della Conformità | 01/06/2025 |
| Società | Posizione | Fine |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 4 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers University- Newark
 Rutgers University- Newark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phathom Pharmaceuticals, Inc.
 Phathom Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel treatments for gastrointestinal diseases and disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
